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Background: Mitogen-activated protein (MAP) kinases (or extracellular signal
regulated kinases; Erks) and stress-activated protein (SAP) kinases mediate
cellular responses to a wide variety of signals. In the Erk MAP kinase pathway,
activation of MAP kinases takes place in the cytoplasm and the activated
enzyme moves to the nucleus. This translocation to the nucleus is essential to
MAP kinase signalling because it enables the kinase to phosphorylate
transcription factors. Whether components of the pathway mediated by the
SAP kinase p38 change their cellular location on activation is not clear; we
have therefore studied the cellular localisation of components of this pathway
before and after stimulation.
Results: The p38 SAP kinase substrate MAP-kinase-activated protein kinase-2
(MAPKAP kinase-2) contains a putative nuclear localisation signal which we
show is functional and required for activation by a variety of stimuli. Following
phosphorylation of MAPKAP kinase-2, nuclear p38 was exported to the
cytoplasm in a complex with MAPKAP kinase-2. Export of MAPKAP kinase-2
required phosphorylation by p38 but did not appear to require the kinase
activity of MAPKAP kinase-2. The p38 activators MKK3 and MKK6 were
present in both the nucleus and the cytoplasm, consistent with a role in
activating p38 in the nucleus.
Conclusions: In the p38 SAP kinase pathway, MAPKAP kinase-2 serves both
as an effector of p38 by phosphorylating substrates and as a determinant of
cellular localisation of p38. Nuclear export of p38 and MAPKAP kinase-2 may
permit them to phosphorylate substrates in the cytoplasm.
Background
The p38 stress-activated protein (SAP) kinases consist of
p38α (also known as SAPK2a, RK, CSBPs, Mxi2 or
Mpk2), p38β (SAPK2b), p38γ (SAPK3) and p38δ (SAPK4)
and are activated by cell stresses such as DNA damage,
heat shock, osmotic shock, anisomycin and sodium arsen-
ite, as well as pro-inflammatory stimuli such as bacterial
lipopolysaccharide and interleukin-1 (reviewed in [1]).
Two splice forms of p38α exist and were originally termed
CSBP1 and CSBP2 [2]. The p38 family mediate cellular
responses such as inflammatory cytokine production and
HSP27 phosphorylation [2,3]. Within the p38 family, p38α
and p38β isoforms, but not p38γ and p38δ, are inhibited
by the pyridinyl imidazole SB203580, which has proved
extremely useful in delineating signalling pathways acti-
vated by cellular stresses and cytokines [1].
Like the mitogen-activated protein (MAP) kinases of the
extracellular signal regulated kinase (Erk) family, which
are mainly stimulated by growth factors, p38 SAP kinases
are activated by phosphorylation on a threonine and a
tyrosine residue in the T-loop; this phosphorylation
results from a protein kinase cascade [4]. Although it is
known that the phosphorylation is mediated by the dual-
specificity kinases MKK3 and MKK6 [5–7], the regulation
of MKK3 and MKK6 is poorly understood. One class of
activators of MKK3 and MKK6 may be the MLK3 family
of protein kinases [8] but there are likely to be others [9].
Activation of the kinase cascade leading to stimulation of
p38 has been shown to require the Rho-subfamily
GTPases Cdc42 and Rac [10] potentially working through
p21-activated kinase (PAK) [11], but the details of this
process remain poorly defined.
Substrates of p38 include MAP-kinase-activated protein
kinase-2 (MAPKAP kinase-2) [12,13], MAPKAP kinase-3
[14] and MAP-kinase-interacting kinase (Mnk) [15,16]
and the transcription factors CHOP [17], Elk-1 and Sap-1a
[18–21]. In the Erk MAP kinase cascade it is clear that
inactive Erk is mainly cytosolic, and that it moves to the
nucleus upon activation [22,23] where it can phosphory-
late nuclear Elk-1 [24]. Presumably active p38 needs to be
nuclear to phosphorylate Elk-1 and other transcription
factors. MAPKAP kinase-2 exists in two alternatively
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spliced variants, one of which contains a potential nuclear
localisation signal (NLS) close to its carboxyl terminus
[25–27]. Nuclear MAPKAP kinase-2 may be required for
the phosphorylation of the transcription factor CREB [28].
If MAPKAP kinase-2 is nuclear then it may need nuclear
p38 to phosphorylate it. We have studied the cellular
localisation of MAPKAP kinase-2 and p38 and investi-
gated whether the potential NLS in the splice variant of
MAPKAP kinase-2 is required for activation. We show
that not only is the NLS-containing splice variant of
MAPKAP kinase-2 nuclear and the NLS required for acti-
vation but that following phosphorylation this kinase
exports activated p38 to the cytoplasm.
Results
MAPKAP kinase-2 has a nuclear localisation signal that is
required for its activation by p38
The potential NLS in human MAPKAP kinase-2 is at
residues 373–389 (KKIEDASNPLLLKRRKK; in single-
letter amino acid code with conserved residues of the
NLS sequence in bold) [26,27] and is conserved in other
species such as the long-tailed hamster (GenBank acces-
sion number X82220). To determine the cellular localisa-
tion of this splice variant we expressed a 9E10
epitope-tagged construct in 293T cells and examined the
cells by immunofluorescence and confocal microscopy.
Figure 1a shows that this protein is nuclear; similar
results were found in PC12 cells (data not shown). To
define whether the potential NLS is functional, we gen-
erated a mutant in which the putative NLS was disrupted
by replacing four basic amino acids (385–388; KRRK)
with asparagine residues (NLS-MAPKAP kinase-2
mutant). As shown in Figure 1a, the NLS-MAPKAP
kinase-2 mutant protein was present mainly in the cyto-
plasmic compartment of the cell. We conclude, therefore,
that the putative NLS is required for nuclear localisation
of this kinase.
To determine whether the nuclear localisation of
MAPKAP kinase-2 was required for activation by p38, we
compared the activation of the NLS-MAPKAP kinase-2
mutant with its wild-type counterpart. As shown in
Figure 1b, the activation of the NLS mutant was severely
compromised in response to all stimuli examined, namely
sodium arsenite, anisomycin and sodium chloride. A glu-
tathione-S-transferase (GST) fusion protein of NLS-
MAPKAP kinase-2 was activated to similar levels as the
wild-type kinase by recombinant p38α in vitro (data not
shown), arguing that the inability to activate NLS-
MAPKAP kinase-2 in vivo is not because the mutant is a
poor substrate of p38. Pretreatment with the p38 inhibitor
SB203580 completely blocked activation of endogenous or
overexpressed MAPKAP kinase-2 by sodium arsenite, ani-
somycin and sodium chloride, demonstrating that activa-
tion of this kinase was mediated principally by p38α or
p38β (data not shown).
Cellular localisation of p38
As nuclear localisation of MAPKAP kinase-2 was
required for its activation we examined whether its 
activator, p38, was in the nucleus. 293T cells were
stained by indirect immunofluorescence with a mono-
clonal antibody against p38. Figure 2a shows that
endogenous p38 in 293T cells growing in 10% serum was
mainly localised to the nucleus. Staining with an anti-
body raised against a phospho-peptide containing the
phosphothreonine and phosphotyrosine in the T-loop —
an antibody which recognises active p38 — showed little
reactivity (Figure 2b). Strikingly, stimulation with
sodium arsenite to activate the p38 protein kinase
cascade led to accumulation of p38 in the cytoplasm. Ten
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Figure 1
MAPKAP kinase-2 has a functional nuclear localisation signal that is
required for activation by p38. (a) Localisation of MAPKAP kinase-2
(MAPKAPK2) and the NLS mutant. Myc-epitope-tagged wild-type
(WT) MAPKAP kinase-2 or NLS-MAPKAP kinase-2 mutant (NLS-
MAPKAPK2) were transfected into 293T cells, the cells fixed and the
Myc epitope tag visualised by indirect immunofluorescence with
mouse monoclonal antibody 9E10. The scale bar in (a) represents
10 µm. (b) Nuclear localisation of MAPKAP kinase-2 is required for
activation. Wild-type MAPKAP kinase-2 or NLS-MAPKAP kinase-2
were transfected into 293T cells; after 40 h, cells were treated with
anisomycin, NaCl or sodium arsenite, lysed, MAPKAP kinase-2 was
immunoprecipitated with mouse monoclonal antibody 9E10 and the
kinase activity measured.
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minutes after stimulation the majority of p38 was found
in the cytoplasm, and staining with the ‘phospho-spe-
cific’ antibody showed that this cytoplasmic p38 was
active (Figure 2a). Similar results were found when p38
was activated by anisomycin (data not shown). In order to
determine whether this relocalisation of p38 following
activation required kinase activity, 293T cells were prein-
cubated with the p38 inhibitor SB203580, treated with
sodium arsenite and then examined by immunofluores-
cence. Figure 2b shows that SB203580 pretreatment
resulted in activated p38 remaining in the nucleus rather
than accumulating in the cytoplasm, as revealed by the
phospho-specific antibody. Similar results were found for
total p38 protein when SB203580-treated cells were
stained with the monoclonal antibody against p38 (data
not shown). These data suggest that p38 is activated in
the nucleus but then exits to the cytoplasm. This export
to the cytoplasm requires the kinase activity of p38
because export was inhibited by SB203580.
In some experiments with 293T cells, particularly when
cells had been in culture for extended periods, we found
that most of the cells had a high level of p38 in the
cytoplasm before sodium arsenite stimulation (Figure 2c).
When such cultures were treated with SB203580 before
staining, however, p38 was found in the nucleus
(Figure 2c). These observations suggest that culture con-
ditions sometimes lead to activation of p38 and, as a con-
sequence, it is exported to the cytoplasm.
MAPKAP kinase-2 moves to the cytoplasm upon activation
induced by sodium arsenite
The observation that activated p38 does not move to the
cytoplasm when cells are pretreated with the p38 inhibitor
SB203580 suggests that phosphorylation of a substrate is
required for nuclear export. Therefore, we examined the
cellular localisation of MAPKAP kinase-2 before and after
sodium arsenite stimulation. Figure 3a shows that
MAPKAP kinase-2 moved to the cytoplasm on sodium
arsenite treatment. Similar results were found in PC12
cells (data not shown).
To examine whether phosphorylation and activation of
MAPKAP kinase-2 were required for nuclear export we
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Figure 2
Endogenous p38 is nuclear and moves to the
cytoplasm upon activation. (a) Unstimulated
293T cells or cells treated with 0.5 mM sodium
arsenite for the indicated times were fixed and
stained with a mouse monoclonal antibody
against p38 (anti-p38) or a rabbit polyclonal
serum raised against the phosphorylated
peptide of the activation loop of p38 (anti-
phospho-p38). (b) The activity of p38 is
required for its exit from the nucleus. 293T cells
were preincubated with 10 µM SB203580 for
30 min before they were treated with sodium
arsenite for 10 min, fixed, and stained for
phospho-p38 as before. (c) Inhibition of p38
activity results in its accumulation in the
nucleus. In these cultures of cells, stained with
anti-p38 to detect total p38, p38 was mainly
cytosolic even before sodium arsenite
treatment; SB203580 treatment resulted in
p38 becoming nuclear, however.
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expressed mutant versions of the protein, and examined
their localisation following sodium arsenite treatment.
The mutant Ala222,334 has two of the three phosphoryla-
tion sites in the protein that are required for its activation
by p38 changed to alanine residues and cannot be acti-
vated by p38 in vitro or in vivo [29,30]. Figure 3b shows
that the Ala222,334 mutant was nuclear in unstimulated
cells and did not move to the cytoplasm following sodium
arsenite stimulation of cells. This result was confirmed by
showing that in cells treated with the p38 inhibitor
SB203580 to block MAPKAP kinase-2 phosphorylation,
MAPKAP kinase-2, like p38, was not exported to the cyto-
plasm (data not shown). These results demonstrate that
phosphorylation of MAPKAP kinase-2 by p38 is required
for nuclear export following activation of p38.
In order to determine whether the catalytic activity of
MAPKAP kinase-2 was required for its export we
expressed a mutant in which Asp207 of the conserved
Asp–Phe–Gly motif was mutated to alanine. Asp207 is
required to coordinate Mg2+ in the Mg2+–ATP complex
and substitution with alanine results in loss of catalytic
activity [31]. Figure 3c shows that the kinase-dead Ala207
MAPKAP kinase-2 mutant was exported upon sodium
arsenite stimulation, suggesting that the catalytic activity
of MAPKAP kinase-2 is not required for export.
Nuclear export of p38 requires co-expression with
MAPKAP kinase-2
To extend our findings on the export of endogenous p38
we examined the cellular localisation of overexpressed
p38. Figure 4a shows that the overexpressed CSBP2
isoform of p38α, revealed by immunofluorescence for the
FLAG epitope in the construct [14], was localised to the
nucleus in growing cells but, unlike endogenous p38, was
not exported to the cytoplasm on activation by sodium
arsenite treatment. Similar results were found with the
CSBP1 isoform (data not shown). The failure of the
exogenous p38 to be exported could result from a failure
of the overexpressed p38 to be activated; Figure 4a shows,
however, that it did become activated because it was
detected by the anti-phospho-p38 antibody following
sodium arsenite treatment.
The results presented in Figure 4a show that when p38 is
overexpressed it cannot be exported from the nucleus sug-
gesting that an endogenous component may be limiting.
Furthermore, the observation that treatment with the p38
inhibitor SB203580 blocks p38 export (Figure 2b,c) suggests
that phosphorylation of this limiting component is required.
As Figure 3a shows that the p38 substrate MAPKAP kinase-
2 was exported from the nucleus following arsenite stimula-
tion in a phosphorylation-dependent manner, we
investigated whether MAPKAP kinase-2 was the limiting
component. Figure 4b shows that when both p38 and
MAPKAP kinase-2 were co-expressed, both the exogenous
proteins were exported to the cytoplasm following activa-
tion of p38 by sodium arsenite treatment. Furthermore, if
p38 was expressed together with Ala222,334 MAPKAP
kinase-2, which fails to be exported, the exogenous p38 was
not exported from the nucleus. We have previously
described a constitutively activated mutant (Aspx3) of
MAPKAP kinase-2 in which all three phosphorylation sites
are replaced by aspartic acid residues to mimic phosphoryla-
tion [29]. This mutant was found to be cytosolic, consistent
with the observations that nuclear export of MAPKAP
kinase-2 requires phosphorylation. Figure 4b shows that
when Aspx3 was co-expressed with p38, the p38 became
cytosolic in the absence of sodium arsenite treatment.
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Figure 3
MAPKAP kinase-2 is exported to the cytoplasm following
phosphorylation by p38. 293T cells were transfected with (a) Myc-
epitope-tagged wild-type (WT), (b) Ala222,334 (non-
phosphorylatable) or (c) Ala207 (kinase-dead) MAPKAP kinase-2 and
treated with sodium arsenite for 15 min, followed by fixation and
indirect immunofluorescence with the 9E10 monoclonal antibody to
detect the Myc tag. The scale bar in (a) represents 10 µm.
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These results argue that phosphorylation of MAPKAP
kinase-2 by p38 not only activates the kinase activity of
MAPKAP kinase-2, so that it can phosphorylate its sub-
strates, but also results in nuclear export of both proteins.
p38 and MAPKAP kinase-2 form a complex in vivo
The observation that export of overexpressed p38
requires co-expression of MAPKAP kinase-2 suggests
that the two proteins form a complex. During screens of
yeast two-hybrid libraries with MAPKAP kinase-2 as bait,
we repeatedly isolated p38 (Figure 5a), suggesting that
these proteins directly interact. To determine whether
such a complex existed in mammalian cells, we expressed
Myc-epitope-tagged MAPKAP kinase-2 and FLAG-
epitope-tagged p38 in 293T cells and carried out recipro-
cal immunoprecipitations and western blots on the
immunoprecipitates. Figure 5b,c shows that MAPKAP
kinase-2 and p38 co-immunoprecipitated and that the
amount of the proteins in the complex was unaffected by
activation of the kinases by treatment of the cells with
sodium arsenite.
Cellular localisation of MKK3 and MKK6
From the observations that nuclear p38 and MAPKAP
kinase-2 are exported to the cytoplasm, it was of interest
to determine the cellular localisation of MKK3 and
MKK6, the dual-specificity kinase activators of p38 [5–7].
Staining of 293T cells with a sheep antibody raised against
an amino-terminal peptide from MKK3 [32] revealed both
cytosolic and nuclear staining (Figure 6). To confirm this
localisation, MKK3 was overexpressed by transfection of a
FLAG-epitope-tagged MKK3 expression vector [5] and
the cells stained with the sheep anti-MKK3 antibody and
a mouse monoclonal antibody against the FLAG epitope.
Figure 6 shows that both antibodies gave an identical
staining pattern consistent with the presence of MKK3 in
both the cytoplasm and the nucleus. Staining for both
endogenous MKK6 with a sheep anti-peptide antibody
[32] and for FLAG-epitope-tagged overexpressed MKK6
[18] in transfected cells revealed a similar distribution to
that of MKK3 (Figure 6). These results show that there is
some MKK3 and MKK6 in the nucleus, consistent with
activation of p38 in the nucleus.
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MAPKAP kinase-2 and p38 are exported together from the nucleus.
(a) Overexpressed p38 is nuclear and fails to be exported to the
cytoplasm. 293T cells were transfected with FLAG-tagged p38,
treated with sodium arsenite for 15 min, followed by fixation and
indirect immunofluorescence with a mouse monoclonal antibody
against the FLAG tag and rabbit antibody against phospho-p38.
(b) Co-expression of wild-type MAPKAP kinase-2 with p38 results in
nuclear export. 293T cells were transfected with p38 together with
Myc-epitope-tagged wild-type (WT), Aspx3 or Ala222,334 MAPKAP
kinase-2, treated with sodium arsenite, followed by fixation and indirect
immunofluorescence with a goat polyclonal antibody against p38 or
with the 9E10 antibody for the Myc tag on the MAPKAP kinase-2
proteins. The scale bar represents 10 µm.
Discussion
We have shown that MAPKAP kinase-2 has a functional
nuclear localisation signal and that its activation by a
variety of stimuli that activate p38 requires nuclear locali-
sation. Our data are consistent with activation of p38
within the nucleus followed by its movement to the cyto-
plasm in a complex with phosphorylated MAPKAP
kinase-2. It is, however, difficult to rule out cytoplasmic
activation of p38 followed by rapid transport to the
nucleus and then export to the cytoplasm. Export from
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Figure 5
The p38 kinase and MAPKAP kinase-2 form a
complex. (a) Two-hybrid analysis in yeast. On
the left are β-galactosidase (β-gal) assays and
growth on medium of the Y190 strain
transformed with 1, pYTH9 MAPKAPK2;
2, pGADGH p38; 3, pYTH9 MAPKAPK2 and
pGADGH p38; 4, pYTH9 and pGADGH p38
on medium lacking histidine, tryptophan and
leucine (–His –Trp –Leu) and containing
3-aminotriazole (+3AT), which is selective for
two-hybrid interaction. On the right is a
β-galactosidase assay of the same
transformants grown on non-selective YPD
medium. (b,c) Complexes of MAPKAP
kinase-2 and p38 in unstimulated mammalian
cells and in cells stimulated with sodium
arsenite. Myc-epitope-tagged MAPKAP
kinase-2 and FLAG-epitope-tagged p38 were
expressed in 293T cells, and
immunoprecipitates (IP) with antibody against
one epitope tag were immunoblotted with
antibody against the other tag. In lanes
labelled HA, immunoprecipitations were
carried out with monoclonal antibody against
the hemagglutinin (HA) epitope tag as an
irrelevant antibody control.
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Figure 6
Cellular localisation of MKK3 and MKK6. For
detection of endogenous proteins, 293T cells
were fixed and (a) MKK3 and (b) MKK6 were
detected by indirect immunofluorescence with
sheep anti-peptide antibodies (anti-MKK3 or
anti-MKK6). To detect exogenous
overexpressed MKK3 or MKK6, 293T cells
were transfected with expression vectors
encoding FLAG-epitope-tagged proteins and,
after fixation, proteins were visualised by
indirect immunofluorescence with (c) sheep
antibodies against MKK3 or (d) MKK6, and
(e,f) a mouse monoclonal antibody against the
FLAG tag. Note the similarity in staining
patterns with the anti-FLAG and sheep
antibodies in the overexpressing cells.
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the nucleus may permit p38 and MAPKAP kinase-2 to be
activated in the nucleus and then phosphorylate cytoplas-
mic substrates. The activation of p38 and MAPKAP
kinase-2 in the nucleus contrasts with the Erk MAP
kinase cascade where Erk and its protein kinase substrate
p90Rsk are activated in the cytoplasm and move to the
nucleus [22]. Thus, unlike the Erk MAP kinase cascade
where the Erk activator — the dual-specificity protein
kinase Mek — is actively excluded from the nucleus by its
nuclear export signal [33], the p38 activators MKK3 and
MKK6 must be able to activate p38 within the nucleus.
Consistent with nuclear activation of p38, we find that
MKK3 and MKK6 are localised in both the cytoplasm and
nucleus, and thus could provide a link between cytoplas-
mic signalling events and nuclear activation of p38.
Recent studies on the activation of p38 by DNA damage
demonstrates that it requires c-Abl, which is activated by
the nuclear kinase DNA-PK [34–36]. As c-Abl is nuclear,
its activation could provide a mechanism for initiating the
p38 cascade within the nucleus.
The localisation of p38 to the nucleus may depend on its
association with nuclear MAPKAP kinase-2, but the obser-
vation that overexpressed p38 is nuclear, without the
requirement for overexpression of MAPKAP kinase-2,
suggests that nuclear localisation of p38 may not require
MAPKAP kinase-2. Export of nuclear p38 to the cyto-
plasm does require MAPKAP kinase-2, because overex-
pressed p38 is not exported to the cytoplasm unless it is
co-expressed with MAPKAP kinase-2, suggesting that the
amount of MAPKAP kinase-2 is limiting. Comparison of
the amounts of endogenous p38 with MAPKAP kinase-2
by immunoblotting with the monoclonal antibody against
p38 and a polyclonal antibody against MAPKAP kinase-2
suggests that there is up to eight times more endogenous
MAPKAP kinase-2 in the cells than p38 (data not shown).
This suggests that not all the endogenous MAPKAP
kinase-2 is complexed to p38. Perhaps the excess of
MAPKAP kinase-2 is to ensure that all the p38 is com-
plexed to it; alternatively, MAPKAP kinase-2 may have
partners other than p38. In addition, p38 could form com-
plexes with its substrates such as Mnk [16]. These issues
will only be resolved when reagents become available to
immunoprecipitate p38, MAPKAP kinase-2 and their
complexes quantitatively.
The export of p38 and MAPKAP kinase-2 from the
nucleus is dependent on the phosphorylation of MAPKAP
kinase-2. As an overexpressed kinase-dead version of
MAPKAP kinase-2 can be exported, this implies that
export does not depend on catalytic activity unless the
endogenous MAPKAP kinase-2 can provide this in trans.
If export requires endogenous MAPKAP kinase-2 activity,
however, then this is not sufficient on its own to permit
export of overexpressed p38, as export of p38 is restored
by overexpression of kinase-dead MAPKAP kinase-2.
Phosphorylation might regulate the cellular location of
MAPKAP kinase-2 by masking the function of the NLS
and thereby altering the balance between nuclear export
and import (see Figure 7 for a model). Phosphorylation of
MAPKAP kinase-2 could also unmask a nuclear export
signal, or permit formation of a complex with a protein
containing an export signal. Export of nuclear MAPKAP
kinase-2 appears to depend on a leucine-rich nuclear
export signal as preliminary experiments (R.W., unpub-
lished observations) show that export is blocked by lepto-
mycin B [37]. While this work was in preparation Engel et
al. [38] reported leptomycin-B-sensitive nuclear export of
phosphorylated MAPKAP kinase-2 and suggested that
there is a nuclear export signal within amino acids 328–351
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Figure 7
A model for the regulation of the nuclear
localisation of MAPKAP kinase-2 and p38 by
phosphorylation. MAPKAP kinase-2 and p38
are complexed together. In unstimulated cells
where p38 is inactive, MAPKAP kinase-2 is
not phosphorylated and its nuclear localisation
signal (NLS) is exposed permitting nuclear
import. In stimulated cells, phosphorylation of
MAPKAP kinase-2 by active p38 leads to a
conformational change in MAPKAP kinase-2
resulting in masking of the NLS and perhaps
unmasking of a nuclear export signal. The net
effect is to lead to relocalisation of the
p38–MAPKAP kinase-2 complex to the
cytoplasm.
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of the protein. They did not, however, describe the export
of p38 in association with MAPKAP kinase-2.
These results show that the cellular localisation of p38
depends on the level of p38 activity and phosphorylation
of MAPKAP kinase-2. From studies on other MAP kinase
pathways it now appears that components of these cas-
cades not only act as kinases but have other functions; for
example, PBS2 in the p38/Hog1 pathway in Saccharomyces
cerevisiae is not only an activator of p38/Hog1 MAP kinase
but is also a ‘scaffold’ protein that brings the components
of the cascade together [39]. Our studies with MAPKAP
kinase-2 show that in the p38 SAP kinase pathway,
MAPKAP kinase-2 serves a dual function, both as an
effector of p38 by phosphorylating substrates such as
Hsp27 and CREB and as a determinant of the localisation
of p38 in the cell.
Materials and methods
Plasmid constructs
Human MAPKAP kinase-2 was subcloned into the NcoI–BamHI sites
of pEF vector [40] to create a 5′ Myc-tagged construct. The NLS-
MAPKAP kinase-2 was generated by exchanging the 3′ end of the
gene with a synthetic oligonucleotide in which the sequence encoding
amino acids 386–389 (Lys–Arg–Arg–Lys) was replaced by four
asparagine residues. The non-phosphorylatable (Ala222,334) and
kinase-dead (Ala207) mutants were created by PCR-mediated mutage-
nesis using oligonucleotides to replace Ser222 and Thr334 or Asp207
with alanine residues. FLAG-tagged p38 (CSBP2) cloned in pCDN
[14] was a gift from Peter Young, SmithKline Beecham.
Immunoprecipitation and kinase assays
The 293T cells were induced with agonists, and cell lysates prepared
in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol,
1% NP-40, 1 mM EGTA, 1 mM sodium vanadate, 50 mM NaF, 3 mM
PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 10 µg/ml pepstatin).
Soluble fractions were then immunoprecipitated with anti-MAPKAP
kinase-2 antibodies bound to protein-G–Sepharose beads for 90 min
at 4°C. Beads were washed three times in lysis buffer. Immunoprecipi-
tates were resolved on 10% SDS–PAGE blotted and probed with anti-
p38 antibodies (Santa Cruz) and anti-rabbit HRP followed by
enhanced chemiluminescence. For kinase assays on immunoprecipi-
tates from transfected cells, expression levels of the Myc-tagged
MAPKAP kinase-2 were first estimated by immunoblotting with 9E10
monoclonal antibody and then equivalent amounts of Myc-tagged
MAPKAP kinase-2 were immunoprecipitated from lysates. Kinase
assays were performed with a peptide substrate as described [29].
Cell culture, transfection, microinjection and
immunofluorescence staining
293T cells were transfected with CaPO4 or microinjected using a
Zeiss-Eppendorf microinjection workstation and analysed after 20 h.
Cells were grown in DMEM plus 10% FCS and stimulated by addition
of 0.5 mM sodium arsenite for 2–20 min, 50 mM anisomycin for
15 min, 300 mM NaCl for 15 min or 100 ng/ml EGF for 10 min.
SB203580 was a gift from SmithKline Beecham and dissolved in
dimethylsulphoxide. It was used at a final concentration of 10 µM and
cells were pretreated for 0.5–1 h. After fixation [41], cells were stained
with mouse monoclonal antibody against recombinant p38 (Zymed)
and a rabbit polyclonal serum raised against amino acids 172–186 of
p38, in which Thr180 and Tyr182 were phosphorylated (New England
Biolabs), followed by TRITC-coupled anti-mouse IgG (Jackson
Immunoresearch) and FITC-coupled anti-rabbit IgG. In some experi-
ments, overexpressed p38 was visualised with a polyclonal goat serum
against p38 (Santa Cruz). The Myc tag on Myc-tagged MAPKAP
kinase-2 was visualised either with mouse monoclonal antibody 9E10
[42] or with a rabbit polyclonal serum (Santa Cruz). The FLAG tag on
pCDN p38/CSBP2 was visualised either with a mouse monoclonal
antibody (IBI-Kodak) or with a rabbit polyclonal serum (Santa Cruz).
FLAG-tagged MKK3 (pRcRSVMKK3) [5] and FLAG-tagged MKK6
(pcDNA3 MKK6) [18] were visualised with a mouse monoclonal anti-
body against FLAG, or sheep anti-peptide antibodies against MKK3 or
MKK6, respectively [32]. Stained cells were viewed on a confocal
imaging system (BIORAD 1024) and fluorescence in each channel
captured separately. Western blots showed that the rabbit anti-
phospho-p38, sheep anti-MKK3, goat anti-p38 and monoclonal anti-
p38 antibodies recognised one major band. Furthermore, when cells
were transfected with expression constructs for the relevant target pro-
teins, cells overexpressing the proteins showed more intense staining
than untransfected surrounding cells.
Two-hybrid analysis in yeast
Human MAPKAP kinase-2 was subcloned into the vector pYTH9 and
integrated into S. cerevisiae strain Y190. A transformant expressing
the Gal4 DNA binding-domain fusion protein was then transformed
with a HeLa two-hybrid library (Clontech). His+ colonies were then
tested for β-galactosidase activity. p38/CSBP2 was recovered many
times from β-galactosidase-positive colonies as well as other
sequences that will be described elsewhere.
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